FDA Inspection 1161844 — Sibyl E. Wray, M.D.
The FDA completed an inspection of Sibyl E. Wray, M.D. on Jan 25, 2022 in Knoxville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 25, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Knoxville, TN (United States)
Additional Details
Clinical Investigator (CI)